439results about How to "Easy to take medicine" patented technology

The invention discloses medicinal liquor for treating rheumatic arthritis and chronic infectious arthritis, which comprises the following raw materials in parts by weight: 33-38 parts of Chinese parsnip root, 8-13 parts of asarum, 28-33 parts of the root of bidentate achyranthes, 28-33 parts of ligusticum sinense oliver, 28-33 parts of notopterygium root, 28-33 parts of radix angelicae pubescentis, 23-28 parts of prepared monkshood, 28-33 parts of cassia twig, 28-33 parts of pawpaw, 28-33 parts of radix clematidis, 28-33 parts of cortex acanthopanacis, 28-33 parts of semen coicis, 28-33 parts of corydalis tuber, 28-33 parts of large-leaved gentian, 4-9 parts of long-noded pit viper, 28-33 parts of the root of fangji, 28-33 parts of rhizoma typhonii, 28-33 parts of ligusticum wallichii, 28-33 parts of zaocys dhumnade, and 7000-8000 parts of 50-60-degree white wine. The medicinal liquor disclosed by the invention has the advantages of being low in cost, high in curative rate and free from toxic and side effects; stimulation of the existing medicines on gastric mucosa is overcome; simultaneously, the medicinal liquor disclosed by the invention also has the functions of tonifying liver and kidney.

The invention discloses an automatic spiral-dressing type dressing changing device. The automatic spiral-dressing type dressing changing device comprises a sickbed body, and wound dressing devices symmetrically arranged on two sides of the sickbed body. Each wound dressing device comprises a support plate, a lifting mechanism slidably connected with the support plate, and a transmission mechanismarranged on the lifting mechanism. Each transmission mechanism comprises a rotating disc and a bandage winding device. Each bandage winding device comprises a screw, a casing sleeving the screw, and atraveling gear in meshed connection with the screw. A central shaft of each traveling gear extends to the outside of a limiting slot to be connected with a 'T'-shaped connecting rod. An elastic bandage fixing clip is connected to the bottom end of each connecting rod through a rotating mechanism. The automatic spiral-dressing type dressing changing device has the advantages that a spirally-reverse folding method is realized through the wound dressing devices to prevent deflection of bandages during dressing, uniformity and firmness in dressing are achieved, and the dressing efficiency is improved; the tensioning degree of the bandages can be automatically adjusted during dressing to avoid loosening of the bandages; the wound dressing devices are pushed below the sickbed body, and accordingly, the occupying space of the wound dressing devices is saved.

The invention relates to a medicament for curing tummy bug, wherein the proportion by weight of the materials of the medicament is that toosendan fruit 6-12, jasmine flower 3-7, paleaceous knotweed 15-25, white peony 10-14, saruma henryi oliv 3-7, corydalis 6-12, cuttlebone 6-12, wilford swallowwort 3-7, linaloe 6-12, dandelion 15-25, cyperus tuber 6-12, stink bug 3 -7, lindera root 6-12, evodia rutaecarpa 7-13; frying immature bitter orange 3-7, frying citrus aurtantium 3-7, ageratum peduncle 1-5, magnolia bark 1-5, sandalwood 4-8, reed rhizome 1-5, zanthoxylum 1-3, spikenard 3-7, kaki calyx3-7, pinellia tuber 6-10, tangerine peel 1-3, and green orange peel 1-5. The medicament of the invention has unique curative effect towards the treatment of chronic superficial gastritis. Compared with the present Chinese patent medicament, the invention has good curative effect, convenient dosing, low curing charge and quick execution. Moreover, the invention can relieve the pain within 6-8 minutes after being taken, and can radically cure the tummy bug without toxic and side effects, and thereby the invention is a perfect Chinese patent medicament for curing tummy bug.

The invention relates to an automatic medicine taking cabinet and a medicine taking method. The automatic medicine taking cabinet comprises a cabinet body, the cabinet body comprises a medicine placing rack, a front panel located in front of the medicine placing rack, a cabinet door located on the rear side of the medicine placing rack, a medicine taking mechanism and a control system. The invention further discloses the medicine taking method. According to the automatic medicine taking cabinet, a medicine taking trolley hopper of the medicine taking mechanism can reach the lower portions of medicine containing bins along medicine taking rail units, walk to the left side of the medicine taking rail units after taking medicines and pour the medicines into an adjacent medicine hopper, and then a medicine collecting trolley reaches the designated medicine outlet position through a lifting unit and a horizontal moving rail unit. By adopting the cooperation of conveyor belts and correlationsensors, the problems of a medicine feeding mode and counting are well solved, and when the medicines are placed, only the cabinet door needs to be opened, the medicines are pushed in from the back,the previous medicines are in the front, the current medicines are in the back, the operation is simple and convenient, and the situation that the previous medicines are out of date due to unreasonable medicine placement can be prevented.

Disclosed is a semi-solid oral formulation of Chinese medicine which comprises traditional Chinese medicinal extract and gel base material, its preparing process comprises the steps of preparing Chinese medicinal extract, dissolving the gel base material, finally mixing the extract with the dissolved gel base material.

A composite medicine for improving the curative effect of the antihypertensive medicine containing Ca channel retardant and preventing the complications such as eyeground hemorrhage, angina pectoris, myocardial infarction, cerebral apoplexy, heart failure and kidney failure is composed of Ca channel vetardant or its precursor or its active metabolite or its salt, one or more of vitamins in B family and the pharmacologically acceptable carrier.

The invention provides an orally disintegrating tablet of levonogestrel and its preparing process, wherein the preparation is prepared by using Levonorgestrel as the medicament, using lactose, mannitol, low substituted methylcellulose propylene glycol ether, magnesium stearate, 95% ethanol, menthol as raw material by a finite proportion, wherein wet method granulation and pelleting are carried out, the prepared orally disintegrating tablet has a hardness of 1.0-3.5 kg, it can be disintegrated within 1 minute, the disintegrated powder can pass through 24 mesh Levonorgestrel disintegrating tablet.

The invention provides a pharmaceutical composition which comprises calcium channel blockers of a medicinal dose, angiotensin II receptor antagonists of a medicinal dose, one or more of B vitamins of a medicinal dose and pharmaceutically acceptable carriers, wherein the calcium channel blockers are selected from amlodipine, felodipine, israbipine, nicardipine, nifedipine, nisoldipine, nitrendipine, lacidipine, diltiazem or verapamil; the angiotensin II receptor antagonists are selected from candesartan, telmisartan, losartan, valsartan, irbesartan, eprosartan, tasosartan or olmesartan; and the B vitamins are selected from one or more of vitamin B6, vitamin B12, folic acid and calcium leucovorin. The pharmaceutical composition of the invention can improve the curative effect of the hypotensor, enhance the target organ protecting action of the hypotensor, and reduce the morbidity of complications of angina, myocardial infarction and the like.

Disclosed is an integrated electric vagina expander, relating to a combined structure of a vagina expander and a colposcope and comprising a detector, a detector permanent seat and a spring regulating mechanism. The spring regulating mechanism is composed of a duck mouth and a duck-mouth open-close device. The duck-mouth open-close device is composed of an open-close shaft and a shell sleeved outside the open-close shaft. A spring is arranged on the open-close shaft, regulating the open and close of the duck mouth. The integrated electric vagina expander which integrates the functions of the vagina expander and the colposcope can achieve continuous operations of examination, sampling and medicine application by a doctor, greatly improving the work efficiency of the doctor; the duck mouth is opened and closed in parallel so that the pain that a patient feels is reduced. In addition the invention is simply structured and produce with low cost.

Belonging to the technical field of medicine, the invention in particular relates to an antiallergic medicine syrup and a preparation method thereof. The medicinal composition contains desloratadine, a cosolvent, an antioxidant, a pH regulator and other pharmaceutically acceptable excipients. The syrup provided by the invention solves the difficult drug taking problem of patients with weak swallowing ability, and ensures simple process, controllable quality and improved stability, thus bettering meeting clinical needs.

The invention provides a pure Chinese traditional medicine preparation for treating psoriasis and multiple skin diseases. The pure Chinese traditional medicine preparation is prepared from the following 21 Chinese traditional medicinal materials: honeysuckle flowers, cortex phellodendri chinensis, flos chrysanthemi indici, glabrous greenbrier rhizome, common ducksmeat herb, yam rhizome, radix rehmanniae, zaocys dhumnade and the like. The pure Chinese traditional medicine preparation provided by the invention has the effects of dispelling wind and nourishing blood, removing dampness to relieve itching, removing pathogenic heat from the blood and toxic materials from the body and supporting the healthy energy, has good treatment effects on the allergic reaction, epidermis proliferation cornification, lichenification, vascular inflammation and hair follicle and sebaceous gland blockage, such as the psoriasis (psora), leucoderma, neurodermatitis, dermatitis, eczema, urticaria, irritability, rubella, comedo, acne and verruca plana, is wide in clinical application treatment range without toxic and side effects, and can not injure the organs and functions of a human body and enhance the physique and the immunity of the human body even if being taken for a long time. A medicament prepared through a preparation method of the pure Chinese traditional medicine preparation is high in dissolution rate and higher in stability.

The invention relates to a medicine composition composed of 0.1-100mg of one of statin lipid regulation medicines, 0.1-5mg of 5-methyltetrahydrofolic acid, and a pharmaceutically acceptable carrier. The invention also provides an application of the medicine composition in preparing medicines used for treating diseases related to hyperlipidemia or dyslipidemia. The composition provided by the invention has the advantages that: with the medicine composition, statin lipid-regulation medicine treatment effect can be improved. The effect is substantially better than other independent-use statin lipid-regulation medicines in the respect of reducing side effects such as transaminase elevation and myopathy caused by long-term and/or large-dose applications of statin medicines, and toxicity is not increased. Also, the composition is more convenient to take. With the composition, medical cost is reduced, and patient compliance is improved.

The invention relates to a pharmaceutical composition containing atenolol, amlodipine, or folic acid compounds and application thereof. The pharmaceutical composition contains an officinal dosage of the atenolol, an officinal dosage of the amlodipine or levamlodipine, an officinal dosage of the folic acid compounds, and a pharmaceutical acceptable carrier. The dosage of the atenolol is between 5 and 50 milligrams, the dosage of the amlodipine or the levamlodipine is between 0.5 and 5.0 milligrams, and the dosage of the folic acid type compounds is between 0.2 and 1.6 milligrams. The pharmaceutical composition has the following advantages: the pharmaceutical composition enhances the hypertension curative effect through multi-target synergistic hypotensive action, and reduces the taking dosage of the amlodipine simultaneously, that is, just about one fourth of the original dosage can achieve the same hypotensive effect and reduce the side effects and medical expenses; and more importantly, the pharmaceutical composition can effectively prevent and treat or delay various complications of high blood pressure cardiovascular and cerebrovascular diseases such as cerebrovascular disorder and the like through dual targets (Hcy and blood pressure) on the basis of reducing toxic side effects. Besides, the pharmaceutical composition ensures that patients can take medicine conveniently.

The invention provides a phloroglucinol oral disintegrating tablet, which takes the phloroglucinol as the active ingredient, and disintegrating agents, fillers, lubricants, flavoring agents, binding agents and effervescent agents are added for preparation. The invention further provides a preparation method of the phloroglucinol oral disintegrating tablet. The phloroglucinol oral disintegrating tablet of the invention not only has the rapid disintegration, good taste and no sense of gravel, but can also can be taken under the condition of no water and have the rapid action and more convenient taking, so the invention can improve the compliance of the patients and the efficacy of the drug and other features of the orally disintegrating tablet, at the same time, the invention has light tablet weight, small volume, no powder falling, good brittleness and better dissolution effect than the freeze-dried orally disintegrating tablet. The production cost is low, the dissolution is faster, the invention is more beneficial to the absorption, and the invention can play the effect of pain reliving faster. The invention has the advantage that the invention can carry out the preparation by only adopting the ordinary pressing equipments and the simple technique without the need of special production equipments and conditions.

There is provided a tablet preparation showing quick disintegratability in the mouth and good sensory acceptability and yet having an adequate strength to resist damage in the course of distribution. Each tablet comprises a starch, a water-soluble excipient and a medicament and does not substantially contain a binder other than starch.

The invention provides a lurasidone hydrochloride orally disintegrating tablet containing indissolvable drugs. The lurasidone hydrochloride orally disintegrating tablet comprises 8%-24% of lurasidone hydrochloride, 8%-48% of a carrier, 0.8%-4% of adhesive, 24%-76.2% of filler, 4%-10% of a disintegrating agent, 2%-6% of flavoring agent and 1%-4% of a lubricating agent. The lurasidone hydrochloride orally disintegrating tablet can be disintegrated quickly, and convenience is provided for medicine taking of patients particularly like the aged, children, coma patients and the patients who cannot take water conveniently. Moreover, the dissolving-out rate can reach 85% or above within 5 minutes. In addition, the lurasidone hydrochloride orally disintegrating tablet can be disintegrated and absorbed quickly in the oral cavity, so that the bioavailability is greatly improved. Operation is easy in production technology, the production cost is low, and the lurasidone hydrochloride orally disintegrating tablet is suitable for industrial mass production.

An oral disintegrating tablet of hypopanaxin for treating the stuffiness and blocking sensation of chest, cardialgia, myocardial ischemia, hemorrhagic shock, etc contains 20-(S)-Rg3, 20-(R)-Rg3, 20-(S)-Rg2, 20-(R)-Rg2, 20-(S)-Rh1, 20-(R)-Rh1 and filler. Its preparing process is also disclosed.

The invention discloses a domestic accompanying robot. The domestic accompanying robot comprising a robot main control unit, a body parameter monitoring unit, a face monitoring unit, a cardiac defibrillation system and a smart medicine box, wherein the body parameter monitoring unit, the face monitoring unit, the cardiac defibrillation system and the smart medicine box are connected with the maincontrol unit; the body parameter monitoring unit acquires data of an external body parameter sensor and transmits the data to the robot main control unit for storage processing; the face monitoring unit acquires a human face image through a camera; the cardiac defibrillation system comprises a defibrillation detection control unit, an electrocardio data acquisition unit, a high-voltage defibrillation unit and defibrillation electrodes; the electrocardio data acquisition unit measures the body impedance between the defibrillation electrodes and the electrocardiosignal of a patient, and the defibrillation detection control unit controls the high-voltage defibrillation unit to apply matched high-voltage pulses to the defibrillation electrodes according to the measurement result; the smart medicine box triggers a medicine box control unit after receiving a medicine taking instruction to rotate a box body and a box lid to the outside of a medicine storage chamber for the user to take medicine. In this way, the robot becomes a safety guarantee for patients at home.